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ABSTRACT
CONTEXT: Anti-glomerular basement membrane (anti-GBM) antibody syndrome is characterized by deposition of anti-GBM antibodies on affected 
tissues, associated with glomerulonephritis and/or pulmonary involvement. This syndrome has been described in association with other autoimmune 
disorders, but as far as we know, it has not been described in association with dermatomyositis and psoriasis. 
CASE REPORT: A 51-year-old man with a history of dermatomyositis and vulgar psoriasis presented with a condition of sensitive-motor polyneuropathy 
of the hands and feet, weight loss of 4 kg, malaise and fever. On admission, he had been making chronic use of cyclosporin and antihypertensive 
drugs for three months because of mild arterial hypertension. Laboratory tests showed anemia and leukocytosis, elevated serum urea and 
creatinine and urine presenting proteinuria, hematuria, leukocyturia and granular casts. The 24-hour proteinuria was 2.3 g. Renal biopsy showed 
crescentic necrotizing glomerulonephritis with linear immunoglobulin G (IgG) deposits on the glomerular basement membrane by means of direct 
immunofluorescence, which were suggestive of anti-GBM antibodies. The patient was then treated initially with methylprednisolone and with monthly 
cyclophosphamide in the form of pulse therapy. 
RESUMO
CONTEXTO: A síndrome do anticorpo anti-membrana basal glomerular (anti-MBG) é caracterizada pela deposição de anticorpos anti-MBG em tecidos 
afetados, associada à glomerulonefrite e/ou ao envolvimento pulmonar. Essa síndrome já foi descrita em associação a outras doenças autoimunes, 
mas até onde conhecemos, não há relatos de sua associação com dermatomiosite e psoríase.
RELATO DE CASO: Um homem de 51 anos com antecedentes de dermatomiosite e psoríase vulgar apresentou quadro de polineuropatia sensitivo-
motora de mãos e pés, perda de 4 kg, adinamia e febre. À admissão estava em uso crônico de ciclosporina e de anti-hipertensivos há três meses 
devido a hipertensão arterial leve. Exames laboratoriais mostraram anemia e leucocitose, creatinina e ureia séricas elevadas e urina com proteinúria, 
hematúria, leucocitúria e cilindros granulosos. A proteinúria de 24 horas foi de 2,3 g. A biópsia renal revelou uma glomerulonefrite crescêntica 
necrotizante com depósitos lineares de imunoglobulina G (IgG) na MBG à imunofluorescência, sugestivos de anticorpos anti-MBG. O paciente foi 
então tratado inicialmente com metilprednisolona e com ciclofosfamida mensalmente na forma de pulsoterapia.
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INTRODUCTION
Dermatomyositis is an autoimmune disease that is characterized 
by involvement of proximal musculature and skin. There are a few cas-
es involving the kidneys, such as membranous and mesangial prolifer-
ative glomerulonephritis.1 Anti-glomerular basement membrane (an-
ti-GBM) antibody disease or Goodpasture’s disease is caused by linear 
deposition of anti-GBM antibodies on the glomerular and/or alveo-
lar basement membrane. It is called Goodpasture’s syndrome when it 
leads to glomerulonephritis and lung hemorrhage. This is a rare con-
dition, with annual incidence of about one case per million people, 
and is more prevalent among white males and, most commonly, in the 
third and seventh decades of life. There is an association with human 
leukocyte antigen (HLA) DR15 or DR4.2-4 
In this study, we present one patient with dermatomyositis and 
vulgar psoriasis who developed anti-GBM disease and was positive for 
perinuclear antineutrophil cytoplasmic antibodies (p-ANCA).
CASE REPORT
In October 2008, a 51-year-old man presented at our hospital 
complaining of a six-day history of weakness of left foot dorsiflexion. 
He had been feeling burning pain, paresthesia and edema of the distal 
legs and hands bilaterally for the previous 40 days. He also reported 
polyarthralgia and weight loss of 4 kg over this period.
He had a past history of dermatomyositis fulfilling the Bohan and 
Peter criteria (proximal muscle weakness, typical rash, elevated se-
rum muscle enzymes and characteristic muscle biopsy abnormalities)5 
Association of anti-glomerular basement membrane antibody disease with dermatomyositis and psoriasis: case report 
Sao Paulo Med J. 2010; 128(5):306-8 307
and biopsy-proven vulgar psoriasis, diagnosed ten and six years earli-
er, respectively. At that time, he was positive for antinuclear antibodies 
(ANA), with a fine speckled pattern at a 1/320 titer and negative for an-
ti-extractable nuclear antigens (anti-ENA). He also reported presenting 
corticosteroid-induced diabetes over a three-month period nine years 
earlier, systemic hypertension for the last six months and previous to-
bacco use. He denied alcohol and drug abuse. The patient was taking cy-
closporin and low doses of losartan, amlodipine and hydrochlorothiaz-
ide. On admission, his body temperature was 37 °C and blood pressure 
was 145/90 mmHg. Physical examination revealed lower-limb edema 
and cutaneous erythematous-desquamative lesions on his wrists, elbows 
and lower back area. He also had severe left-foot weakness due to dorsi-
flexion, and hypoesthesia of his hands and lateral left distal leg.
The laboratory tests on admission showed mild anemia (hemoglo-
bin: 11.2 g/dl), leukocytosis (18,000 cells/mm3), elevated serum urea 
(94 mg/dl) and creatinine (2.09 mg/dl) and an abnormal urinalysis with 
proteinuria, blood, leukocyturia and granular casts. The 24-hour protei-
nuria was 2.31 g. He also presented elevated erythrocyte sedimentation 
rate (86 mm/hour) and C-reactive protein concentration (138.15 mg/l). 
Serological tests for hepatitis B and C and human immunodeficiency vi-
rus (HIV) were all negative.
Tests for ANA, anti-ENA, anti-Jo1 and anti-PMScl antibodies were 
all negative, with normal complement, and p-ANCA tested positive us-
ing indirect immunofluorescence, with a 1:80 titer. Percutaneous needle 
renal biopsy showed crescentic necrotizing glomerulonephritis (Figure 1) 
with linear immunoglobulin G (IgG) deposits on the glomerular base-
ment membrane by means of direct immunofluorescence, which were 
suggestive of anti-GBM antibodies (Figure 2). Electroneuromyography 
showed motor-sensitive axonal polyneuropathy in the lower extremities, 
associated with mononeuropathy of the left fibular nerve. Investigation of 
paraneoplastic syndrome was negative, including abdominal, chest and 
prostatic tumors. 
A diagnosis of anti-GBM disease was made and treatment was be-
gun with steroid pulse therapy (methylprednisolone 1 g/day for three 
days) and monthly intermittent intravenous cyclophosphamide (dose: 
0.5 g/m2). After six months of intravenous cyclophosphamide, the pa-
tient persisted with abnormalities of urinary sediment and 24-hour pro-
teinuria of 6 gm. Thus, pulse therapy was replaced by oral cyclophos-
phamide at a dose of 150 mg/day, which led to partial remission of the 
renal disease and corticosteroid taper-off within three months.   
DISCUSSION
The patient reported here developed signs of glomerulonephritis 
within a few years after dermatomyositis had been diagnosed. This led 
to the clinical suspicion of either renal involvement in this inflammato-
ry myopathy or a syndrome overlapping with another connective tissue 
disease or systemic vasculitis. Therefore, renal biopsy was indicated, and 
this confirmed the presence of anti-GBM disease. 
The presence of peripheral polyneuropathy was another confound-
ing factor in this case, since this is an unusual manifestation of anti-
GBM disease. An association between glomerulonephritis and periph-
eral polyneuropathy may be encountered in diseases such as ANCA-as-
sociated vasculitis, cryoglobulinemia and systemic lupus erythematosus. 
Moreover, it is well known that Goodpasture’s syndrome classically pres-
ents with glomerulonephritis and pulmonary hemorrhage. This may be 
accompanied by systemic symptoms and, less often, by peripheral neu-
ropathy, arthritis, leukocytoclastic vasculitis and uveitis. In the absence 
of pulmonary involvement, the diagnosis is referred to as anti-GBM 
disease.2-4
ANCA is found in 30 to 47% of patients with anti-GBM disease 
and thus, histological evidence is of paramount importance for correct 
diagnosis of anti-GBM disease, because patients might be erroneously 
treated for ANCA-associated vasculitis.3 The pathogenic effects of anti-
GBM was demonstrated by Lerner et al. through the induction of glom-
erulonephritis in monkeys.6 ANCA is also known to have pathogenic 
effects when binding to myeloperoxidase (MPO) or proteinase 3 (PR3) 
on the surface of primed neutrophils. It leads to activation of these cells 
and their migration to and adhesion onto the endothelium, along with 
release of proteolytic enzymes, proinflammatory cytokines and reactive 
Figure 1. Kidney section stained with hematoxylin and eosin at 20 X 
magnification, showing crescentic glomerulonephritis with glomerular sclerosis. 
Figure 2. Direct immunofluorescence of kidney biopsy showing linear 
glomerular deposits (20 X magnification).
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oxygen species, which eventually causes endothelial cell damage.7 Nev-
ertheless, the pathophysiological roles of the two antibodies occurring in 
patients with anti-GBM disease are not completely understood. Some 
authors have suggested that ANCA could initiate damage to the glom-
erular basement membrane, thereby exposing antigens that were previ-
ously hidden and triggering the production of anti-GBM antibodies.8,9
The management of Goodpasture’s syndrome and anti-GBM dis-
ease includes plasmapheresis, in order to remove pathogenic antibodies 
associated with immunosuppression and thereby inhibit antibody pro-
duction and avoid rebound hypersynthesis of antibodies following with-
drawal of plasmapheresis. High-dose corticosteroids and cyclophosph-
amide are mostly used, and the duration of therapy with the latter is 
approximately six months.2-4 Notwithstanding these recommendations, 
our patient was managed successfully with immunosuppressive drugs 
alone, because of the unavailability of plasmapheresis at the time when 
he was acutely ill.
Other factors that may have contributed towards a favorable re-
sponse in this case were the absence of the so-called poor prognostic 
signs of Goodpasture’s syndrome (e.g. oliguria, advanced kidney fibro-
sis, serum creatinine > 5.7 mg/dl or dialysis4) in our patient. However, 
patients with both antibodies have similar renal survival to those with 
anti-GBM antibodies alone.10
CONCLUSIONS
This is the first case in which an association of anti-GBM antibody 
syndrome with dermatomyositis and psoriasis has been described. We 
performed an electronic search in the Pubmed and Lilacs (Literatura La-
tino-Americana e do Caribe em Ciências da Saúde) databases to confirm 
the lack of previous reports on such an association between dermatomy-
ositis, psoriasis, ANCA and anti-GBM disease in the medical literature 
(Table 1). This case is useful for reminding clinicians and rheumatolo-
gists about the importance of correct investigation and precise diagno-
sis for patients with autoimmune rheumatic diseases presenting with 
atypical manifestations. Adequate patient history-taking, physical ex-
amination, laboratory tests and auto-antibody investigation, along with 
histopathological evidence of tissue involvement, should guide the di-
agnosis. 
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Table 1. Search strategy with MeSH (Medical Subject Headings) terms used by the authors on August 28, 2009
Database Search strategy Results
PubMed Dermatomyositis AND Psoriasis AND (Antibodies, antineutrophil cytoplasmic) AND (Anti-glomerular basement membrane disease) 0
Literatura Latino-Americana e do Caribe 
em Ciências da Saúde (Lilacs)
Dermatomiosite AND Psoríase AND ANCA AND Doença do anticorpo antimembrana basal glomerular 0
